MDx Firm Genomic Vision Launches French IPO | GenomeWeb

NEW YORK (GenomeWeb News) – French molecular diagnostics company Genomic Vision today announced the launch of its initial public offering.

It plans to offer about 1.3 million shares of its stock at an expected price range of between €13.5 ($18.61) and €16.5 per share. At the midpoint of the range, the IPO is anticipated to raise about €20 million ($27.6 million), Genomic Vision said. The company plans to list its shares on Euronext Paris.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.